⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BMY News
Bristol-Myers Squibb Co.
Autoimmune CAR T Safety Events Reshape Rheumatologist Sentiment, but Autologous CAR T Retains Lead, According to Spherix Global Insights
globenewswire.com
NVS
BMY
Global Liver Cancer Diagnostics Market to Observe Impressive Growth at a CAGR of ~9% by 2034 | DelveInsight
globenewswire.com
LLY
MRK
GSK
BMY
AZN
PFE
NVO
REGN
RDHL
AGIO
INCY
CRBP
BMRN
VKTX
RIGL
DTIL
CRDF
BIIB
ALKS
EXAS
CLDX
SRPT
TGTX
ALNY
CHKP
TAK
HHS
SERV
GILD
HRMY
IONS
BH
FORM
JNJ
GEN
ABBV
AMGN
CRSP
CHRD
ADPT
IMUX
ALGN
EXEL
VRTX
Caspian Therapeutics Appoints Manasi Jaiman, M.D., M.P.H., and Elizabeth Mily to Board of Directors
globenewswire.com
KURA
BMY
VRTX
TMO
KRAS Inhibitors - Market Size, Target Population, Competitive Landscape and Forecast - 2036 | Pan-KRAS Pipelines and New Cancer Indications Drive 7MM Growth
globenewswire.com
AMGN
BMY
VERA
AZN
MRK
Atherosclerotic Cardiovascular Disease (ASCVD) Market Insights, Epidemiology, and Forecast - 2036 | 7MM Market to Reach USD 40 Billion as Precision Therapies Reshape Growth
globenewswire.com
AMGN
ARWR
NVS
ALNY
SNY
REGN
ESPR
JNJ
AZN
AMRN
MRK
LLY
BMY
ON
NVO
Global Lightweight Materials Market Size, Share, Trends, and Forecast, 2026-2031 | EV and Aerospace Demand to Drive 8.72% CAGR, Reaching $354.33 Billion
globenewswire.com
AA
AL
F
PCAR
GD
BA
LMT
RTX
NOC
HXL
AVAV
ADI
TXN
NVDA
AMD
INTC
MSFT
AMZN
GOOGL
IBM
GE
CAT
DE
MMM
DD
ALGN
XRAY
MRNA
PFE
JNJ
BIIB
GILD
REGN
VRTX
AMGN
BMY
ABBV
LLY
TSLA
NIO
RIVN
LCID
GM
STLA
HMC
TM
VWAGY
XPEV
LI
BYDDF
CHPT
PLUG
FCEL
SPWR
ENPH
SEDG
NEE
EXC
BEP
IRTC
RCL
CCL
NCLH
HAL
SLB
DV
BNTX
CRSP
EDIT
NTLA
XOM
CVX
COP
SBLK
ZIM
GNK
TECK
RIO
BHP
VALE
NEM
FCX
AVNT
NNDM
SSYS
CRON
TLRY
ACB
CGC
PYPL
COIN
BITF
MARA
RIOT
CLSK
PLTR
SNOW
CRWD
PANW
SMCI
EXAS
TDOC
CI
UNH
CVS
QCOM
NXPI
ON
AEHR
AMAT
LRCX
KLAC
MU
WDC
Global Drug Discovery Market (2026-2031) - AI-Driven Target Identification Accelerates Growth
globenewswire.com
NVDA
LLY
CHAI
TMO
ABBV
AMGN
AZN
BDX
BMY
CRL
JNJ
MRK
NVS
PFE
REGN
SNY
VRTX
U.S. Food and Drug Administration Approves Expanded Indication for Bristol Myers Squibb’s CAMZYOS ® (mavacamten) for the Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) in Adults and Pediatric Patients*
businesswire.com
BMY
Coronary Artery Disease Clinical Trial Space Intensifies with 20+ Companies in Active Development | DelveInsight
globenewswire.com
CYTK
NVO
BCDA
AZN
MESO
GEHC
BSX
MDT
ABT
LIVN
OSCR
EL
BMY
ARE
AVT
RNTX
IPO Education Foundation Names Medtronic's Dr. William J. Peine as 2026 Inventor of the Year
prnewswire.com
MDT
BMY